Regulation of Inflammation by Short Chain Fatty Acids

Overview

Journal Nutrients

Date 2012 Jan 19

PMID 22254083

Citations 663

Authors

Marco A R Vinolo

Hosana G Rodrigues

Renato T Nachbar

Rui Curi

Affiliations

Soon will be listed here.

Abstract

The short chain fatty acids (SCFAs) acetate (C(2)), propionate (C(3)) and butyrate (C(4)) are the main metabolic products of anaerobic bacteria fermentation in the intestine. In addition to their important role as fuel for intestinal epithelial cells, SCFAs modulate different processes in the gastrointestinal (GI) tract such as electrolyte and water absorption. These fatty acids have been recognized as potential mediators involved in the effects of gut microbiota on intestinal immune function. SCFAs act on leukocytes and endothelial cells through at least two mechanisms: activation of GPCRs (GPR41 and GPR43) and inhibiton of histone deacetylase (HDAC). SCFAs regulate several leukocyte functions including production of cytokines (TNF-α, IL-2, IL-6 and IL-10), eicosanoids and chemokines (e.g., MCP-1 and CINC-2). The ability of leukocytes to migrate to the foci of inflammation and to destroy microbial pathogens also seems to be affected by the SCFAs. In this review, the latest research that describes how SCFAs regulate the inflammatory process is presented. The effects of these fatty acids on isolated cells (leukocytes, endothelial and intestinal epithelial cells) and, particularly, on the recruitment and activation of leukocytes are discussed. Therapeutic application of these fatty acids for the treatment of inflammatory pathologies is also highlighted.

Citing Articles

Antioxidant Activities of the Cell-Free Supernatant of a Potential Probiotic Cutibacterium acnes Strain CCSM0331, Isolated From a Healthy Skin.

Shao L, Huang J, Li Y, Ma L, Niu Y, Jiang W J Cosmet Dermatol. 2025; 24(3):e70105.

PMID: 40071444 PMC: 11897930. DOI: 10.1111/jocd.70105.

Beta-Hydroxybutyrate Attenuates Bronchial Smooth Muscle Pro-Inflammatory Cytokine Production.

Fastiggi V, Mank M, Poynter M bioRxiv. 2025; .

PMID: 40027689 PMC: 11870512. DOI: 10.1101/2025.02.19.639048.

Microbiome Modulation in Pediatric Leukemia: Impact on Graft-Versus-Host Disease and Treatment Outcomes: A Narrative Review.

Todor S, Ichim C Children (Basel). 2025; 12(2).

PMID: 40003268 PMC: 11854176. DOI: 10.3390/children12020166.

Short-Chain Fatty Acids and Their Metabolic Interactions in Heart Failure.

Chulenbayeva L, Issilbayeva A, Sailybayeva A, Bekbossynova M, Kozhakhmetov S, Kushugulova A Biomedicines. 2025; 13(2).

PMID: 40002756 PMC: 11853371. DOI: 10.3390/biomedicines13020343.

Mental Health Disorders Due to Gut Microbiome Alteration and NLRP3 Inflammasome Activation After Spinal Cord Injury: Molecular Mechanisms, Promising Treatments, and Aids from Artificial Intelligence.

Kalaga P, Ray S Brain Sci. 2025; 15(2).

PMID: 40002529 PMC: 11852823. DOI: 10.3390/brainsci15020197.

References

Sina C, Gavrilova O, Forster M, Till A, Derer S, Hildebrand F . G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. J Immunol. 2009; 183(11):7514-22. DOI: 10.4049/jimmunol.0900063. View

Griffin W . Inflammation and neurodegenerative diseases. Am J Clin Nutr. 2006; 83(2):470S-474S. DOI: 10.1093/ajcn/83.2.470S. View

Plaisancie P, Dumoulin V, Chayvialle J, Cuber J . Luminal peptide YY-releasing factors in the isolated vascularly perfused rat colon. J Endocrinol. 1996; 151(3):421-9. DOI: 10.1677/joe.0.1510421. View

Cavaglieri C, Nishiyama A, Fernandes L, Curi R, Miles E, Calder P . Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes. Life Sci. 2003; 73(13):1683-90. DOI: 10.1016/s0024-3205(03)00490-9. View

Vijay-Kumar M, Aitken J, Carvalho F, Cullender T, Mwangi S, Srinivasan S . Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science. 2010; 328(5975):228-31. PMC: 4714868. DOI: 10.1126/science.1179721. View

Inatomi O, Andoh A, Kitamura K, Yasui H, Zhang Z, Fujiyama Y . Butyrate blocks interferon-gamma-inducible protein-10 release in human intestinal subepithelial myofibroblasts. J Gastroenterol. 2005; 40(5):483-9. DOI: 10.1007/s00535-005-1573-4. View

Niederman R, Lu B, Robinson P, Naleway C . Short-chain carboxylic acid concentration in human gingival crevicular fluid. J Dent Res. 1997; 76(1):575-9. DOI: 10.1177/00220345970760010801. View

MILLARD A, Mertes P, Ittelet D, Villard F, Jeannesson P, Bernard J . Butyrate affects differentiation, maturation and function of human monocyte-derived dendritic cells and macrophages. Clin Exp Immunol. 2002; 130(2):245-55. PMC: 1906513. DOI: 10.1046/j.0009-9104.2002.01977.x. View

Park J, Woo M, Kim S, Kim W, Kim H . Repression of interferon-gamma-induced inducible nitric oxide synthase (iNOS) gene expression in microglia by sodium butyrate is mediated through specific inhibition of ERK signaling pathways. J Neuroimmunol. 2005; 168(1-2):56-64. DOI: 10.1016/j.jneuroim.2005.07.003. View

10.

Murphy E, Cotter P, Healy S, Marques T, OSullivan O, Fouhy F . Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut. 2010; 59(12):1635-42. DOI: 10.1136/gut.2010.215665. View

11.

Dagtas A, Edens R, Gilbert K . Histone deacetylase inhibitor uses p21(Cip1) to maintain anergy in CD4+ T cells. Int Immunopharmacol. 2009; 9(11):1289-97. DOI: 10.1016/j.intimp.2009.07.012. View

12.

Nishimura T, Andoh A, Hashimoto T, Kobori A, Tsujikawa T, Fujiyama Y . Cellobiose Prevents the Development of Dextran Sulfate Sodium (DSS)-Induced Experimental Colitis. J Clin Biochem Nutr. 2010; 46(2):105-10. PMC: 2831088. DOI: 10.3164/jcbn.09-72. View

13.

Kim H, Rowe M, Ren M, Hong J, Chen P, Chuang D . Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J Pharmacol Exp Ther. 2007; 321(3):892-901. DOI: 10.1124/jpet.107.120188. View

14.

Saemann M, Bohmig G, Osterreicher C, Burtscher H, Parolini O, Diakos C . Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production. FASEB J. 2000; 14(15):2380-2. DOI: 10.1096/fj.00-0359fje. View

15.

Park J, Lee E, Lee J, Kim W, Kim H . Anti-inflammatory effects of short chain fatty acids in IFN-gamma-stimulated RAW 264.7 murine macrophage cells: involvement of NF-kappaB and ERK signaling pathways. Int Immunopharmacol. 2006; 7(1):70-7. DOI: 10.1016/j.intimp.2006.08.015. View

16.

Tao R, de Zoeten E, Ozkaynak E, Chen C, Wang L, Porrett P . Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med. 2007; 13(11):1299-307. DOI: 10.1038/nm1652. View

17.

Zapolska-Downar D, Naruszewicz M . Propionate reduces the cytokine-induced VCAM-1 and ICAM-1 expression by inhibiting nuclear factor-kappa B (NF-kappaB) activation. J Physiol Pharmacol. 2009; 60(2):123-31. View

18.

Wang H, Bloom O, Zhang M, Vishnubhakat J, Ombrellino M, Che J . HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999; 285(5425):248-51. DOI: 10.1126/science.285.5425.248. View

19.

Ulloa L, Tracey K . The "cytokine profile": a code for sepsis. Trends Mol Med. 2005; 11(2):56-63. DOI: 10.1016/j.molmed.2004.12.007. View

20.

Vinolo M, Rodrigues H, Hatanaka E, Sato F, Sampaio S, Curi R . Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J Nutr Biochem. 2010; 22(9):849-55. DOI: 10.1016/j.jnutbio.2010.07.009. View